Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol.
Spiekman IAC, Geurts BS, Zeverijn LJ, de Wit GF, van der Noort V, Roepman P, de Leng WWJ, Jansen AML, Kusters B, Beerepoot LV, de Vos FYFL, de Groot DA, de Groot JWB, Hoeben A, Buter J, Gelderblom HAJ, Voest EE, Verheul HMW. Spiekman IAC, et al. Among authors: gelderblom haj. Oncologist. 2024 May 3;29(5):431-440. doi: 10.1093/oncolo/oyad320. Oncologist. 2024. PMID: 38109296 Free PMC article.
Individualized Dosing Patterns in the Treatment of Older Patients with Gastrointestinal Stromal Tumors: Results of a Registry-Based Observational National Cohort Study Including 871 Patients.
Bleckman RF, Broekman KE, Roets E, Mohammadi M, Desar IME, Gelderblom H, Mathijssen RHJ, Steeghs N, de Graeff P, Reyners AKL. Bleckman RF, et al. Drugs Aging. 2024 Feb;41(2):165-176. doi: 10.1007/s40266-023-01084-8. Epub 2023 Dec 20. Drugs Aging. 2024. PMID: 38123766
Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor-stroma ratio in colon cancer.
Polack M, Smit MA, van Pelt GW, Roodvoets AGH, Meershoek-Klein Kranenbarg E, Putter H, Gelderblom H, Crobach ASLP, Terpstra V, Petrushevska G, Gašljević G, Kjær-Frifeldt S, de Cuba EMV, Bulkmans NWJ, Vink GR, Al Dieri R, Tollenaar RAEM, van Krieken JHJM, Mesker WE; UNITED Collaboration. Polack M, et al. ESMO Open. 2024 Apr;9(4):102988. doi: 10.1016/j.esmoop.2024.102988. Epub 2024 Apr 12. ESMO Open. 2024. PMID: 38613913 Free PMC article.
Thromboembolic and bleeding complications during interruptions and after discontinuation of anticoagulant treatment in patients with atrial fibrillation and active cancer: A daily practice evaluation.
Chu G, Seelig J, Cannegieter SC, Gelderblom H, Hovens MMC, Huisman MV, van der Hulle T, Trines SA, Vlot AJ, Versteeg HH, Hemels M, Klok FA. Chu G, et al. Thromb Res. 2023 Oct;230:98-104. doi: 10.1016/j.thromres.2023.08.016. Epub 2023 Aug 30. Thromb Res. 2023. PMID: 37703801 Free article.
Adjuvant immune checkpoint blockade revisited.
van Waalwijk van Doorn-Khosrovani SB, Huisman A, Roy AP, Koole S, Timmers L, Blank C, Gelderblom H. van Waalwijk van Doorn-Khosrovani SB, et al. Lancet Oncol. 2023 Jul;24(7):717-719. doi: 10.1016/S1470-2045(23)00233-4. Lancet Oncol. 2023. PMID: 37414008 No abstract available.
Evaluation of response to neoadjuvant chemotherapy in osteosarcoma using dynamic contrast-enhanced MRI: development and external validation of a model.
Kalisvaart GM, Van Den Berghe T, Grootjans W, Lejoly M, Huysse WCJ, Bovée JVMG, Creytens D, Gelderblom H, Speetjens FM, Lapeire L, van de Sande MAJ, Sys G, de Geus-Oei LF, Verstraete KL, Bloem JL. Kalisvaart GM, et al. Skeletal Radiol. 2024 Feb;53(2):319-328. doi: 10.1007/s00256-023-04402-8. Epub 2023 Jul 18. Skeletal Radiol. 2024. PMID: 37464020 Free PMC article.